
Robert B. Beatty
Examiner (ID: 170, Phone: (571)272-2130 , Office: P/2852 )
| Most Active Art Unit | 2852 |
| Art Unit(s) | 2105, 2852 |
| Total Applications | 3107 |
| Issued Applications | 2812 |
| Pending Applications | 78 |
| Abandoned Applications | 258 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17206614
[patent_doc_number] => 11166965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-09
[patent_title] => Compositions for use in stimulating bone growth
[patent_app_type] => utility
[patent_app_number] => 16/870224
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 7014
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870224
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870224 | Compositions for use in stimulating bone growth | May 7, 2020 | Issued |
Array
(
[id] => 16204807
[patent_doc_number] => 20200237797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => ANTI-TUMOR COMPOUND WITH HIGH CD169 AFFINITY, METHOD THEREOF, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/847770
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16847770
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/847770 | Anti-tumor compound with high CD169 affinity, method thereof, and use thereof | Apr 13, 2020 | Issued |
Array
(
[id] => 16204966
[patent_doc_number] => 20200237956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => Homogeneous Aqueous Solution of Injectable Chitosan
[patent_app_type] => utility
[patent_app_number] => 16/845422
[patent_app_country] => US
[patent_app_date] => 2020-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16845422
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/845422 | Homogeneous Aqueous Solution of Injectable Chitosan | Apr 9, 2020 | Abandoned |
Array
(
[id] => 16686743
[patent_doc_number] => 20210069218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => METHODS OF CONTROLLING TUMOR BIOENERGETICS NETWORKS
[patent_app_type] => utility
[patent_app_number] => 16/833144
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18414
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16833144
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/833144 | METHODS OF CONTROLLING TUMOR BIOENERGETICS NETWORKS | Mar 26, 2020 | Abandoned |
Array
(
[id] => 17407193
[patent_doc_number] => 11248063
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Derivatives of N-desulfated glycosaminoglycans and use as drugs
[patent_app_type] => utility
[patent_app_number] => 16/823068
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6773
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823068
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823068 | Derivatives of N-desulfated glycosaminoglycans and use as drugs | Mar 17, 2020 | Issued |
Array
(
[id] => 17407193
[patent_doc_number] => 11248063
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Derivatives of N-desulfated glycosaminoglycans and use as drugs
[patent_app_type] => utility
[patent_app_number] => 16/823068
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6773
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823068
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823068 | Derivatives of N-desulfated glycosaminoglycans and use as drugs | Mar 17, 2020 | Issued |
Array
(
[id] => 17407193
[patent_doc_number] => 11248063
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Derivatives of N-desulfated glycosaminoglycans and use as drugs
[patent_app_type] => utility
[patent_app_number] => 16/823068
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6773
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823068
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823068 | Derivatives of N-desulfated glycosaminoglycans and use as drugs | Mar 17, 2020 | Issued |
Array
(
[id] => 16221255
[patent_doc_number] => 20200246371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => MALTOSYL-ISOMALTOOLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 16/789920
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24294
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16789920
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/789920 | Maltosyl-isomaltooligosaccharides | Feb 12, 2020 | Issued |
Array
(
[id] => 18301088
[patent_doc_number] => 11622974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-11
[patent_title] => Prebiotic composition and its use
[patent_app_type] => utility
[patent_app_number] => 16/743806
[patent_app_country] => US
[patent_app_date] => 2020-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 24114
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16743806
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/743806 | Prebiotic composition and its use | Jan 14, 2020 | Issued |
Array
(
[id] => 17937019
[patent_doc_number] => 11471451
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Uses of crenolanib
[patent_app_type] => utility
[patent_app_number] => 16/738108
[patent_app_country] => US
[patent_app_date] => 2020-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13213
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 249
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16738108
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/738108 | Uses of crenolanib | Jan 8, 2020 | Issued |
Array
(
[id] => 17073738
[patent_doc_number] => 11110117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Skin preparation composition for external use containing complex hyaluronic acid
[patent_app_type] => utility
[patent_app_number] => 16/738357
[patent_app_country] => US
[patent_app_date] => 2020-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10005
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16738357
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/738357 | Skin preparation composition for external use containing complex hyaluronic acid | Jan 8, 2020 | Issued |
Array
(
[id] => 16822652
[patent_doc_number] => 20210137945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => METHOD FOR TREATING A CANCER ASSOCIATED WITH THE ACTIVATION OF GALECTIN-1
[patent_app_type] => utility
[patent_app_number] => 16/681822
[patent_app_country] => US
[patent_app_date] => 2019-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16681822
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/681822 | METHOD FOR TREATING A CANCER ASSOCIATED WITH THE ACTIVATION OF GALECTIN-1 | Nov 12, 2019 | Abandoned |
Array
(
[id] => 17922812
[patent_doc_number] => 11466045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Mithramycin oxime derivatives having increased selectivity and anti-cancer activity
[patent_app_type] => utility
[patent_app_number] => 16/670707
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 28
[patent_no_of_words] => 11810
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16670707
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/670707 | Mithramycin oxime derivatives having increased selectivity and anti-cancer activity | Oct 30, 2019 | Issued |
Array
(
[id] => 15646715
[patent_doc_number] => 20200085887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => DIETARY SUPPLEMENTS CONTAINING PROBIOTICS
[patent_app_type] => utility
[patent_app_number] => 16/670459
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16670459
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/670459 | DIETARY SUPPLEMENTS CONTAINING PROBIOTICS | Oct 30, 2019 | Abandoned |
Array
(
[id] => 15524907
[patent_doc_number] => 20200054759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO
[patent_app_type] => utility
[patent_app_number] => 16/666310
[patent_app_country] => US
[patent_app_date] => 2019-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16666310
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/666310 | Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo | Oct 27, 2019 | Issued |
Array
(
[id] => 15432365
[patent_doc_number] => 20200030365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => PHARMACEUTICAL COMPOSITIONS WITH HYDRATING AND LUBRICATING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/593616
[patent_app_country] => US
[patent_app_date] => 2019-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3734
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16593616
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/593616 | Pharmaceutical compositions with hydrating and lubricating activity | Oct 3, 2019 | Issued |
Array
(
[id] => 15738397
[patent_doc_number] => 20200108086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => ANTIVIRAL SUPPLEMENT FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/582657
[patent_app_country] => US
[patent_app_date] => 2019-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13560
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16582657
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/582657 | Antiviral supplement formulations | Sep 24, 2019 | Issued |
Array
(
[id] => 15264931
[patent_doc_number] => 20190381199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR THE DETECTION AND TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/555290
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555290
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/555290 | Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders | Aug 28, 2019 | Issued |
Array
(
[id] => 15524725
[patent_doc_number] => 20200054668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => SULPHATED XYLANS FOR TREATMENT OR PROPHYLAXIS OF RESPIRATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/551002
[patent_app_country] => US
[patent_app_date] => 2019-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16551002
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/551002 | SULPHATED XYLANS FOR TREATMENT OR PROPHYLAXIS OF RESPIRATORY DISEASES | Aug 25, 2019 | Abandoned |
Array
(
[id] => 15551735
[patent_doc_number] => 20200060279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => USE OF SILTHIOFAM FOR THE TREATMENT OF SOYBEAN RUST
[patent_app_type] => utility
[patent_app_number] => 16/549134
[patent_app_country] => US
[patent_app_date] => 2019-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16549134
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/549134 | Use of silthiofam for the treatment of soybean rust | Aug 22, 2019 | Issued |